Mark D. McKee
Impact in
-
- Breast Cancer Treatment Studies
-
- PARP inhibition in cancer therapy
- Lung Cancer Research Studies
- Global Cancer Incidence and Screening
Papers in
- Oncology 5
-
- PI3K/AKT/mTOR signaling in cancer 2
- Protein Degradation and Inhibitors 1
- Histone Deacetylase Inhibitors Research 1
- Co-authors
- Charles E. Geyer (2 shared papers)Jens Huober (2 shared papers)Gϋnter von Minckwitz (2 shared papers)David Maag (2 shared papers)Stephanie M. Wong (1 shared paper)Joyce O’Shaughnessy (1 shared paper)Danielle Sullivan (2 shared papers)Norman Wolmark (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Cancer (1 paper)Clinical Cancer Research (1 paper)OncoTargets and Therapy (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Mark D. McKee
9 papers receiving 254 citations
Peers
Comparison fields: 5 of 64
- Cancer Research 107
- Oncology 137
- Pathology and Forensic Medicine 47
- Pulmonary and Respiratory Medicine 39
- Molecular Biology 80
Countries citing papers authored by Mark D. McKee
This map shows the geographic impact of Mark D. McKee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark D. McKee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark D. McKee more than expected).
Fields of papers citing papers by Mark D. McKee
This network shows the impact of papers produced by Mark D. McKee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark D. McKee. The network helps show where Mark D. McKee may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark D. McKee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 89 | |
| 2 | 2016 | 65 | |
| 3 | 2017 | 41 | |
| 4 | 2002 | 28 | |
| 5 | 2015 | 13 | |
| 6 | 2014 | 12 | |
| 7 | 2018 | 8 | |
| 8 | 2017 | 2 | |
| 9 | 2017 | 1 |
About Mark D. McKee
Mark D. McKee is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Pathology and Forensic Medicine, having authored 9 papers that have together received 259 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers), Cancer Genomics and Diagnostics (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Breast Lesions and Carcinomas (2 papers), Protein Degradation and Inhibitors (1 paper), Medical Imaging Techniques and Applications (1 paper) and Histone Deacetylase Inhibitors Research (1 paper). The work is most often cited by research in Cancer Research (107 citations), Oncology (137 citations), Pathology and Forensic Medicine (47 citations), Pulmonary and Respiratory Medicine (39 citations) and Molecular Biology (80 citations). Mark D. McKee has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Charles E. Geyer, Jens Huober, Gϋnter von Minckwitz, David Maag, Stephanie M. Wong, Joyce O’Shaughnessy, Danielle Sullivan, Norman Wolmark, Otto Metzger and Hope S. Rugo. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Clinical Cancer Research, OncoTargets and Therapy and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.